FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development June 24, 2025July 9, 2025 Share More from the Blog Customer Spotlight: Queen Mary University of London’s Centre for Predictive in vitro Models Read More Emulate Liver-Chip S1 Accepted into FDA’s ISTAND Pilot Program. What’s Next? Read More Providing Rapid Scientific Insights with a Human-Relevant COVID-19 Lung Model Read More Browse All